AzTrials
AzTrials

Newborn, TransientVIRGINANCT04483869

Infrared Thermography and Apgar Score

An observational study of Newborn, Transient, run by Poissy-Saint Germain Hospital at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Background: The Apgar score assesses the newborn's adaptation in the first minutes of life. It is rated between 0 and 10 by the midwife, at 1-3-5 and 10 minutes of life. A low Apgar score at 5 minutes of life is associated with increased neonatal mortality and neurological impairment. Read more about this study

Who is it for?
Ages Up to 15 minutesHealthy volunteers can take part
Conditions the study is for
Newborn, Transient
What is being tested?
Thermography
How many people
200 participants
Where
1 siteFrance
Study dates
23 Jul 2020to Jul 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 15 minutes
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Term newborn, born after cesarean delivery, without congenital anomalies

Who may be able to join

  • term infants, gestational age ≥ 37 weeks of gestation
  • cesarean delivery
  • maternal age ≥ 18 years

Who cannot join

  • parents refusal
  • congenital anomalies

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Poissy Saint Germain Hospital

    Poissy, 78300

    Mathilde P. Letouzey, MD, +33139274430, mathilde.letouzey@gmail.com

    Recruiting

Other trials in France

About this study

Official title: Infrared Thermography and Apgar Score: Evaluation in Delivery Room for Term Newborn

Background: The Apgar score assesses the newborn's adaptation in the first minutes of life. It is rated between 0 and 10 by the midwife, at 1-3-5 and 10 minutes of life. A low Apgar score at 5 minutes of life is associated with increased neonatal mortality and neurological impairment. However, this score has limitations and its measurement remains subjective: it does not guide resuscitation actions in the event of poor adaptation, significant inter-observer variability in scoring, variations according to the physiological maturation of the newborn, in particular according to gestational age.

Infrared thermography is a rapidly developing imaging technique based on the measurement of infrared radiation. It is an accurate, reliable and easy instrument of providing rapid non-contact, non-invasive and non-irradiating diagnosis. A recent 2018 study showed that the use of thermography would allow accurate and non-invasive monitoring of newborns in neonatal intensive care unit for early diagnosis of certain pathologies such as infection. During the transition, during the first minutes of life, the circulatory and respiratory systems of the newborn change. Vasodilatation occurs progressively in the central and peripheral areas. Thermoregulation is also a crucial stage of adaptation.

Read more

In view of this physiopathological knowledge, it seems interesting to correlate this adaptation , with the analysis of thermographic images. The principle of this technique is indeed based on the analysis of the heat emitted, and would thus make it possible to evaluate the blood perfusion of the newborn, and its evolution in the first minutes of life in an objective way. Our hypothesis is that a poor adaptation could be detected more efficiently on photographs taken at time T, contrary to the calculation of the Apgar score for which there are several limitations mentioned above.

Main objective of the study: To study the ability of the thermographic image to objectively evaluate the adaptation to ectopic life of newborns compared to existing evaluations (Apgar, pH, Lactates).

Being tested
Thermography
Keywords
thermography, apgar score

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ThermographyOther

    thermographic image a 1, 3, 5 et 10 minutes of life

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. thermographic image

    Correlation between thermographic image and Apgar score

    Measured: 1 minute of life

  2. thermographic image

    Correlation between thermographic image and Apgar score

    Measured: 5 minutes of life

  3. thermographic image

    Correlation between thermographic image and Apgar score

    Measured: 10 minutes of life

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2020
  2. Study start23 Jul 2020
  3. Primary completion23 Jul 2020
  4. Study completionJul 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04483869
Sponsor's protocol ID
2020-A00265-34
Acronym
VIRGINA
Status last verified
Jul 2020
First submitted
9 Jul 2020
Last updated
27 Jul 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Letouzey M, Diop S, Kengoum CEP, Rousseau A, Hot N, Francois J, Quibel T, Berveiller P, Boileau P, Jouen F, Trabelsi I, Bergounioux J. Newborn clinical condition assessment using infrared thermography: correlation with the Apgar score in a prospective cohort study. Front Pediatr. 2025 Dec 12;13:1636667. doi: 10.3389/fped.2025.1636667. eCollection 2025.

    PubMed 41458084

Questions about this trial

What is this clinical trial studying?

An observational study of Newborn, Transient, run by Poissy-Saint Germain Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

thermographic image (time frame: 1 minute of life). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04483869, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in